OptiNose Inc Stock Price and Quote (2024)

Held by: VTI IWM VXF IWO VTWO IWC VTWG VTHR URTY UWM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.32	Insider Own	28.71%	Shs Outstand	112.40M	Perf Week	-13.30%
Market Cap	183.62M	Forward P/E	-	EPS next Y	-0.09	Insider Trans	-0.33%	Shs Float	80.31M	Perf Month	10.88%
Income	-35.53M	PEG	-	EPS next Q	-0.11	Inst Own	56.98%	Short Float	4.00%	Perf Quarter	42.98%
Sales	70.99M	P/S	2.59	EPS this Y	18.53%	Inst Trans	-0.27%	Short Ratio	6.03	Perf Half Y	31.45%
Book/sh	-0.77	P/B	-	EPS next Y	65.04%	ROA	-28.21%	Short Interest	3.21M	Perf Year	-1.81%
Cash/sh	0.65	P/C	2.49	EPS next 5Y	-	ROE	-	52W Range	0.90 - 2.10	Perf YTD	26.36%
Dividend Est.	-	P/FCF	-	EPS past 5Y	34.78%	ROI	-	52W High	-22.38%	Beta	-0.23
Dividend TTM	-	Quick Ratio	0.55	Sales past 5Y	95.85%	Gross Margin	87.52%	52W Low	81.11%	ATR (14)	0.14
Dividend Ex-Date	-	Current Ratio	0.60	EPS Y/Y TTM	63.98%	Oper. Margin	-32.04%	RSI (14)	46.90	Volatility	11.89% 9.40%
Employees	132	Debt/Eq	-	Sales Y/Y TTM	-6.93%	Profit Margin	-50.06%	Recom	1.00	Target Price	3.75
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	44.39%	Payout	-	Rel Volume	1.44	Prev Close	1.66
Sales Surprise	3.12%	EPS Surprise	4.66%	Sales Q/Q	-4.75%	Earnings	Mar 07 BMO	Avg Volume	533.12K	Price	1.63
SMA20	-8.18%	SMA50	8.05%	SMA200	27.20%	Trades		Volume	769,659	Change	-1.81%

open in yahoo|&nbspopen in reuters|&nbspopen in marketwatch|&nbspopen in google|&nbspopen in EDGAR

Date	Action	Analyst	Rating Change	Price Target Change
Mar-11-24	Initiated	H.C. Wainwright	Buy	$5
Aug-21-23	Initiated	Lake Street	Buy	$3
Oct-21-22	Resumed	Jefferies	Buy	$5
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$17
Dec-18-19	Initiated	Cowen	Outperform	$25
Aug-08-18	Initiated	Cantor Fitzgerald	Overweight

Mar-15-24 03:34PM	XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps (GlobeNewswire)
Mar-08-24 09:50AM	OptiNose, Inc. (NASDAQ:OPTN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-07-24 09:41PM	Q4 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents)
01:54PM	OptiNose Inc (OPTN) Reports Decline in 2023 Revenue Amidst Preparations for Potential XHANCE ... (GuruFocus.com)
12:52PM	OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:15AM	OptiNose (OPTN) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:33AM	OptiNose: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights (GlobeNewswire)
Feb-29-24 04:40PM	Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results (GlobeNewswire)
Jan-18-24 12:00PM	Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice (GlobeNewswire)
Dec-06-23 07:00AM	Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE (GlobeNewswire) -16.33%
Nov-22-23 09:00AM	Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-11-23 11:37AM	OptiNose, Inc. (NASDAQ:OPTN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:05AM	OptiNose Inc (OPTN) Reports Q3 2023 Financial Results with Improved Operating Efficiency (GuruFocus.com)
07:25AM	OptiNose: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Optinose Reports Third Quarter 2023 Financial Results and Operational Updates (GlobeNewswire)
Oct-27-23 08:00AM	Optinose Announces Reporting Date for Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-24-23 12:00PM	OptiNose (OPTN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-22-23 09:01AM	Optinose to Present at the 2023 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-12-23 09:58AM	OptiNose, Inc. (NASDAQ:OPTN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 08:54PM	Q2 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents) +6.90%
08:25AM	OptiNose (OPTN) Q2 Earnings and Revenues Top Estimates (Zacks)
07:27AM	OptiNose: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Optinose Reports Second Quarter 2023 Financial Results and Operational Updates (GlobeNewswire)
Aug-09-23 07:55PM	Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -5.69%
Jul-27-23 07:00AM	Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million (GlobeNewswire)
Jul-07-23 08:28AM	When Will OptiNose, Inc. (NASDAQ:OPTN) Breakeven? (Simply Wall St.)
Jun-16-23 04:08PM	Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-10-23 08:16AM	OptiNose, Inc. (NASDAQ:OPTN) is definitely on the radar of institutional investors who own 39% of the company (Simply Wall St.)
Jun-02-23 01:00PM	Optinose to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-14-23 08:08AM	US$4.17: That's What Analysts Think OptiNose, Inc. (NASDAQ:OPTN) Is Worth After Its Latest Results (Simply Wall St.)
May-11-23 10:43PM	Q1 2023 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents) +6.45%
08:55AM	OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:54AM	OptiNose: Q1 Earnings Snapshot (AP Finance)
07:00AM	Optinose Reports First Quarter 2023 Financial Results and Operational Updates (GlobeNewswire)
May-04-23 07:00AM	Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE (GlobeNewswire) +11.43%
May-01-23 04:30PM	Optinose Announces Reporting Date for First Quarter 2023 Financial Results (GlobeNewswire)
Apr-18-23 12:43PM	OptiNose, Inc.'s (NASDAQ:OPTN) Business Is Trailing The Industry But Its Shares Aren't (Simply Wall St.)
08:00AM	Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-12-23 04:00PM	Optinose to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-11-23 07:29AM	OptiNose, Inc. (NASDAQ:OPTN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-09-23 06:24AM	We're Not Very Worried About OptiNose's (NASDAQ:OPTN) Cash Burn Rate (Simply Wall St.) -8.42%
Mar-07-23 11:22PM	Q4 2022 OptiNose Inc Earnings Call (Thomson Reuters StreetEvents)
08:35AM	OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights (GlobeNewswire)
Mar-06-23 02:03AM	Silence Therapeutics PLC Sponsored ADR (SLN) Stock Jumps 9.3%: Will It Continue to Soar? (Zacks) +5.56%
Feb-28-23 04:30PM	Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results (GlobeNewswire)
Feb-21-23 02:29PM	Bucks County firm seeks to expand approval for flagship product (American City Business Journals)
07:00AM	Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion (GlobeNewswire)
Jan-31-23 12:03PM	Optinose CEO Peter Miller resigns after 13 years; successor named (American City Business Journals)
07:00AM	Optinose Announces CEO Transition and Business Update (GlobeNewswire)
Dec-27-22 09:27AM	OptiNose, Inc.'s (NASDAQ:OPTN) top owners are private equity firms with 37% stake, while33% is held by institutions (Simply Wall St.)
Dec-15-22 04:30PM	Optinose Appoints Paul Spence as Chief Commercial Officer (GlobeNewswire)
Dec-09-22 08:00AM	Optinose Announces Departure of Acting Chief Financial Officer (GlobeNewswire) -7.94%
Nov-30-22 07:00AM	Optinose Announces Corporate Updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-22-22 02:24PM	Bucks County health care company expects to raise $50M (American City Business Journals) +5.71%
Nov-21-22 08:30AM	Optinose Announces Pricing of Public Offering of Common Stock and Warrants (GlobeNewswire) -7.89%
06:12AM	Optinose Announces Proposed Public Offering of Common Stock and Warrants (GlobeNewswire)
Nov-16-22 05:24AM	Analysts Are More Bearish On OptiNose, Inc. (NASDAQ:OPTN) Than They Used To Be (Simply Wall St.)
Nov-12-22 07:54AM	OptiNose Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Nov-10-22 08:15AM	OptiNose (OPTN) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -15.08%
08:00AM	Edited Transcript of OPTN.OQ earnings conference call or presentation 10-Nov-22 1:00pm GMT (Thomson Reuters StreetEvents)
07:00AM	Optinose Reports Third Quarter 2022 Financial Results and Operational Updates (GlobeNewswire)
Nov-09-22 03:00PM	Optinose Announces ReOpen2 Presentation at the American College of Asthma, Allergy, and Immunology (ACAAI) 2022 Annual Scientific Meeting (GlobeNewswire) -6.34%
Nov-07-22 03:00PM	Optinose Announces Reporting Date for Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-21-22 07:00AM	Optinose Announces Late Breaking Abstract Podium Presentation at IDWeek 2022 (GlobeNewswire)
Oct-16-22 08:24AM	Shareholders in OptiNose (NASDAQ:OPTN) are in the red if they invested five years ago (Simply Wall St.)
Sep-18-22 10:44AM	When Can We Expect A Profit From OptiNose, Inc. (NASDAQ:OPTN)? (Simply Wall St.)
Sep-06-22 12:00PM	Optinose Announces ReOpen1 Abstract Selected for Presentation at the American Rhinologic Society Annual Meeting (GlobeNewswire)
Aug-17-22 10:00AM	2 Stocks That Should Perform Well Even if Consumers Pull In Their Horns (TheStreet.com)
Aug-11-22 08:15AM	OptiNose (OPTN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:00AM	Optinose Reports Second Quarter 2022 Financial Results and Operational Updates (GlobeNewswire)
Aug-08-22 04:20PM	Optinose Announces Reporting Date for Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-14-22 08:45AM	10 Best Penny Stocks to Buy in July (Insider Monkey)
Jul-13-22 10:58AM	Pooled Data Show Optinose's XHANCE Cut Sinusitis Flares By 66% (Benzinga)
07:44AM	Organogenesis (ORGO) Stock Jumps 5.3%: Will It Continue to Soar? (Zacks)
07:00AM	Optinose Announces that XHANCE Significantly Reduced Incidence of Exacerbations for Patients with Chronic Sinusitis in Landmark ReOpen Program (GlobeNewswire)
Jul-08-22 08:23AM	Optinose Shared Additional Encouraging Data From Late-Stage Chronic Sinusitis Studies (Benzinga)
07:00AM	Optinose Announces Additional Positive Results from ReOpen2 and Initial Results from Pooled Analyses of Both Trials in the ReOpen Program (GlobeNewswire)
Jun-13-22 11:10AM	Optinose Stock Moves Higher On Positive Second Chronic Sinusitis Phase 3 Trial (Benzinga) +41.08%
07:00AM	Optinose Announces Positive Top-line Results of ReOpen2, its second Phase 3 Clinical Trial of XHANCE for Treatment of Chronic Sinusitis (GlobeNewswire)
Jun-03-22 07:00AM	Optinose Announces Departure of Chief Financial Officer (GlobeNewswire)
May-12-22 08:15AM	OptiNose (OPTN) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -5.38%
07:00AM	Optinose Reports First Quarter 2022 Financial Resultsand Operational Updates (GlobeNewswire)
May-10-22 07:15AM	Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-09-22 05:35PM	Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -9.26%
May-05-22 05:00PM	Optinose Announces Reporting Date for First Quarter 2022 Financial Results (GlobeNewswire)
Apr-26-22 08:00AM	Optinose Announces Appointment of R. John Fletcher to the Board (GlobeNewswire)
Apr-08-22 08:30AM	Optinose to Present at the Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-08-22 08:15AM	OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -6.55%
07:00AM	Optinose Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights (GlobeNewswire)
Mar-07-22 07:00AM	Optinose Reports Positive Top-line Results in ReOpen1, a Landmark Phase 3 Trial for XHANCE in Chronic Sinusitis (GlobeNewswire)
Mar-04-22 02:00PM	Optinose Announces Reporting Date for Fourth Quarter 2021 Financial Results (GlobeNewswire)
Feb-23-22 03:00PM	OptiNose (OPTN) May Report Negative Earnings: Know the Trend Ahead of Q4 Release (Zacks)
Jan-24-22 09:40AM	Is NuCana PLC Sponsored ADR (NCNA) Outperforming Other Medical Stocks This Year? (Zacks)
Dec-28-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-21-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-17-21 06:52AM	Rising P/E: An Overlooked Trick to Land on 5 Winning Stocks (Zacks)
Dec-16-21 09:38AM	Opaleye Management Inc. Buys Semler Scientific Inc, Keros Therapeutics Inc, Crinetics ... (GuruFocus.com)
Dec-13-21 07:54AM	Optinose Announces Appointment of Two New Members to Board of Directors (GlobeNewswire)

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mahmoud Ramy A	Chief Executive Officer	Mar 18 '24	Sale	1.88	19,198	36,092	1,331,278	Mar 19 12:43 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Mar 18 '24	Sale	1.88	15,059	28,311	602,268	Mar 19 12:45 PM
Krick Anthony J	Chief Accounting Officer	Mar 18 '24	Sale	1.88	2,345	4,409	143,988	Mar 19 12:46 PM
Mahmoud Ramy A	Chief Executive Officer	Jan 31 '24	Sale	1.31	52,875	69,266	548,387	Feb 01 02:43 PM
Mahmoud Ramy A	Chief Executive Officer	Dec 18 '23	Sale	1.15	11,114	12,781	509,728	Dec 20 12:21 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Dec 18 '23	Sale	1.15	5,005	5,756	333,511	Dec 20 12:20 PM
Mahmoud Ramy A	Chief Executive Officer	Sep 18 '23	Sale	1.37	11,083	15,184	514,729	Sep 19 07:05 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Sep 18 '23	Sale	1.37	4,991	6,838	334,699	Sep 19 07:04 PM
Mahmoud Ramy A	Chief Executive Officer	Jun 16 '23	Sale	1.15	3,543	4,074	519,699	Jun 20 01:03 PM
Marino Michael F III	Chief Legal Officer & Corp Sec	Jun 16 '23	Sale	1.15	1,516	1,743	335,873	Jun 20 01:04 PM

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions withourpremium features. Real-time quotes, advancedvisualizations, backtesting, and much more.

Learn more about FINVIZ*Elite